Quote:
Adipose tissue until recently was considered to be poor grafting material in tissue reconstruction. Pioneering work by Sidney Coleman MD on processing techniques for fat grafting led to its increased use. As adipose tissue grafting became widespread its regenerative properties came to the fore as surgeons noticed unexpected skin rejuvenation, scar resolution, and most remarkably reversal of hitherto intractable conditions such as radiation fibrosis. In the late ’90s under the direction of William Futrell MD at the University of Pittsburgh, Adam Katz MD first isolated and recognized the abundant presence of MSC’s (mesenchymal stem cells) in adipose tissue, thus providing the key to understanding the regenerative potential of Adipose tissue which is contained in its Stromal Vascular Fraction (SVF). Building on this foundation, Peter Rubin MD has created a powerhouse engine of academic research and the central nexus for Adipose tissue and SVF science at the University of Pittsburgh. Bringing SVF technologies to market is a arduous process but William Cimino PhD, CEO of GID *******has proven autologous SVF therapy is not only market ready, but already being deployed in several countries successfully.*******
SVFC is up soon....count on it.
AI
